Clinical trial efficacy

Proven at

HUMIRA clinical trial efficacy at 16 weeks

Proven skin clearance (PASI 75 or PGA 0/1) at week 16 for most HUMIRA-treated patients vs placebo1-3

HUMIRA clinical trial efficacy at 1 year

Skin clearance maintained at 52 weeks for many HUMIRA-treated patients vs placebo1,8,9

HUMIRA clinical trial efficacy at 3 years

Skin clearance assessed at 3 years of continuous HUMIRA therapy10

Well-studied safety data

surfer with board

Well-known safety profile in clinical trials.1,4,5

Every-other-week dosing

Every-other-week dosing schedule starting one week after initial dose.1

HUMIRA Citrate-free

No citrate buffers, thinner needle, less pain immediately following injection compared with the HUMIRA 40 mg/0.8 mL presentation.11†‡

HUMIRA Citrate-free is available to all indicated patients in the United States. HUMIRA Citrate-free features the same safety and efficacy profile of HUMIRA you've come to count on.
Injection site pain immediately following injection as measured using a 0-10 cm Visual Analog Scale: HUMIRA 40 mg/0.4 mL vs HUMIRA 40 mg/0.8 mL.